Adapted Physical Activity in Patients With Lower Limb Peripheral Arterial Disease
A legfontosabb adatok
- Ki végzi
- Centre Hospitalier le Mans
- Hol
- Le Mans (Franciaország)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 70 fő, tervezett
- Kezdés
- 2021. febr. 11.
- Tervezett befejezés
- 2026. nov. 11.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- muscle strengthening targeted on ischemic areas
- global muscle strenghtening
- A regiszteradat frissítve
- 2026. július 1.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with peripheral arterial disease of the legs who get leg pain when walking. It compares two adapted exercise programs.
- Életkor
- Over 18
- Nem
- All
- A betegség stádiuma
- Lower limb peripheral arterial disease with IPSC < 0.90, narrowed leg arteries and intermittent claudication (muscle pain when walking that stops with rest).
- Biomarker vagy leletérték
- IPSC (ankle-arm blood pressure index) < 0.90
A részvétel fő kizáró okai
- Severe or unstable heart or lung disease that rules out exercise training
- Unstable angina or heart attack in the last 3 months
- Known NYHA grade III or IV heart failure
- Severe joint or rheumatic disease of the legs, or wide skin disease of the legs
- Amputation of a limb with a device, Parkinson's disease, hemiplegia or paraplegia
A regiszter feltételei, szó szerint
Mind a 16 feltétel megnézéseKevesebb
Ki vehet részt
- Patient with Lower Limb Peripheral Arterial Disease with IPSC < 0.90, arterial stenosis in the lower limbs and intermittent claudication
- No contraindication to physical activity
- Socially insured patients over 18
- Patient who has signed the consent form
Ki nem vehet részt
- Any event (injury, surgery, etc.) occurring during the protocol period that could have an impact on results
- Unstable angina or myocardial infarction <3 months
- Known NYHA grade III or IV heart failure
- Parkinson's disease, hemiplegia or paraplegia
- Severe or unstable cardiopulmonary pathologies, contraindicating exercise training
- Severe rheumatological pathology of the lower limbs
- Amputee of a lower or upper limb fitted with a device
- Extensive dermatosis of the lower limbs
- Known severe respiratory pathology
- Adults subject to enhanced protection, deprived of their liberty by judicial or administrative decision
- Persons unable to consent
- Be in a period of exclusion from other interventional research
Ez a vizsgálat jelenleg itt érhető el: Franciaország.
- Centre Hospitalier du MansLe Mans, FranciaországContact: Christelle JADEAURésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The prevalence of peripheral arterial disease is 12.2% in France. Intermittent claudication is the most common symtom of this disease. During physical exercise, such as walking, blood oxygen (O2) requirements increase. The development of atherosclerosis in the lower limbs, causes narrowing of the arteries and limits the increase in blood flow required for muscular effort. Patients then experience muscle pain, the intensity of which gradually increases until it forces them to stop. After stopping, the pain subsides and disappears in less than 10 minutes.
A teljes eredeti leírásKevesebb
The location of the pain (calves and/or thighs and/or buttocks) is related to the location of the ischemia (distal in the calf, proximal in the thigh or buttock, or proximo-distal if several locations). This can have different consequences on the biomechanical parameters of walking and muscle activity. To date, the impact of this localization on physical capacity has never been studied.
These limitations are very disabling and impact the quality of life of patients.
In addition, poor lower limb performance is associated with higher mortality. Reducing symptomatology and improving functional abilities is therefore a major issue in patients with peripheral arterial disease. This can be achieved through the practice of an Adapted Physical Activity, an essential recommendation in the care of patients with peripheral arterial disease.
Our main hypothesis is that the physical activity rehabilitation protocol "Activ'AO" will improve the functional capacities of patients with peripheral arterial disease who have followed the program with the localization of ischemia with a greater consideration than in patients in the group following a "standard" APA protocol. Improvements in functional abilities (such as walking) will lead to improvements in quality of life.
A vizsgálat 2 csoportja
- APA with consideration of ischemia localizationA vizsgált kezelés
Kezelés: muscle strengthening targeted on ischemic areas
- APA without consideration of ischemia localizationA vizsgált kezelés
Kezelés: global muscle strenghtening
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Adapted Physical Activity in Patients With Lower Limb Peripheral Arterial Disease (ACTIV'AO)
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. július 1.